84 related articles for article (PubMed ID: 21326329)
21. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
Falcone M; Rajan AJ; Bloom BR; Brosnan CF
J Immunol; 1998 May; 160(10):4822-30. PubMed ID: 9590229
[TBL] [Abstract][Full Text] [Related]
22. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
Toft-Hansen H; Babcock AA; Millward JM; Owens T
J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
[TBL] [Abstract][Full Text] [Related]
25. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
[TBL] [Abstract][Full Text] [Related]
26. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
27. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
28. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis.
Butti E; Bergami A; Recchia A; Brambilla E; Del Carro U; Amadio S; Cattalini A; Esposito M; Stornaiuolo A; Comi G; Pluchino S; Mavilio F; Martino G; Furlan R
Gene Ther; 2008 Apr; 15(7):504-15. PubMed ID: 18239607
[TBL] [Abstract][Full Text] [Related]
29. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
31. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
32. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
[TBL] [Abstract][Full Text] [Related]
33. GFAP mRNA fluctuates in synchrony with chronic relapsing EAE symptoms in SJL/J mice.
Kothavale A; Di Gregorio D; Somera FP; Smith ME
Glia; 1995 Jul; 14(3):216-24. PubMed ID: 7591033
[TBL] [Abstract][Full Text] [Related]
34. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
Krakowski ML; Owens T
Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
[TBL] [Abstract][Full Text] [Related]
35. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
[TBL] [Abstract][Full Text] [Related]
36. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
Hofstetter HH; Toyka KV; Gold R
Neurosci Lett; 2006 Jan; 391(3):127-30. PubMed ID: 16198481
[TBL] [Abstract][Full Text] [Related]
37. Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis.
Martín-Saavedra FM; Flores N; Dorado B; Eguiluz C; Bravo B; García-Merino A; Ballester S
Mol Immunol; 2007 Jul; 44(14):3597-607. PubMed ID: 17420051
[TBL] [Abstract][Full Text] [Related]
38. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats.
Diab A; Zhu J; Xiao BG; Mustafa M; Link H
J Neuropathol Exp Neurol; 1997 Jun; 56(6):641-50. PubMed ID: 9184655
[TBL] [Abstract][Full Text] [Related]
39. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach.
Martino G; Poliani PL; Furlan R; Marconi P; Glorioso JC; Adorini L; Comi G
J Neuroimmunol; 2000 Jul; 107(2):184-90. PubMed ID: 10854655
[TBL] [Abstract][Full Text] [Related]
40. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
Poliani PL; Brok H; Furlan R; Ruffini F; Bergami A; Desina G; Marconi PC; Rovaris M; Uccelli A; Glorioso JC; Penna G; Adorini L; Comi G; 't Hart B; Martino G
Hum Gene Ther; 2001 May; 12(8):905-20. PubMed ID: 11387056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
